CDX2 and neoplasm: Compared to CDX2-high neoplasms, CDX2-low/absent CRCs were also more frequent in high-grade CRCs according to the WHO grade and tumours with intermediate (Bd2) or high (Bd3) tumour budding activity as well as in MSI-H CRCs (P < 0.001, respectively).